Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1186/s13073-016-0290-3

http://scihub22266oqcxt.onion/10.1186/s13073-016-0290-3
suck pdf from google scholar
C4823848!4823848 !27056827
unlimited free pdf from europmc27056827
    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid27056827
      Genome+Med 2016 ; 8 (1 ): 37
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions #MMPMID27056827
  • Baxter NT ; Ruffin MT 4th ; Rogers MA ; Schloss PD
  • Genome Med 2016[Apr]; 8 (1 ): 37 PMID27056827 show ga
  • BACKGROUND: Colorectal cancer (CRC) is the second leading cause of death among cancers in the United States. Although individuals diagnosed early have a greater than 90% chance of survival, more than one-third of individuals do not adhere to screening recommendations partly because the standard diagnostics, colonoscopy and sigmoidoscopy, are expensive and invasive. Thus, there is a great need to improve the sensitivity of non-invasive tests to detect early stage cancers and adenomas. Numerous studies have identified shifts in the composition of the gut microbiota associated with the progression of CRC, suggesting that the gut microbiota may represent a reservoir of biomarkers that would complement existing non-invasive methods such as the widely used fecal immunochemical test (FIT). METHODS: We sequenced the 16S rRNA genes from the stool samples of 490 patients. We used the relative abundances of the bacterial populations within each sample to develop a random forest classification model that detects colonic lesions using the relative abundance of gut microbiota and the concentration of hemoglobin in stool. RESULTS: The microbiota-based random forest model detected 91.7% of cancers and 45.5% of adenomas while FIT alone detected 75.0% and 15.7%, respectively. Of the colonic lesions missed by FIT, the model detected 70.0% of cancers and 37.7% of adenomas. We confirmed known associations of Porphyromonas assaccharolytica, Peptostreptococcus stomatis, Parvimonas micra, and Fusobacterium nucleatum with CRC. Yet, we found that the loss of potentially beneficial organisms, such as members of the Lachnospiraceae, was more predictive for identifying patients with adenomas when used in combination with FIT. CONCLUSIONS: These findings demonstrate the potential for microbiota analysis to complement existing screening methods to improve detection of colonic lesions.
  • |*Microbiota [MESH]
  • |*Models, Biological [MESH]
  • |Adult [MESH]
  • |Aged [MESH]
  • |Aged, 80 and over [MESH]
  • |Colonic Diseases/*diagnosis/*etiology [MESH]
  • |Feces/*chemistry/*microbiology [MESH]
  • |Female [MESH]
  • |Gastrointestinal Microbiome [MESH]
  • |Humans [MESH]
  • |Immunochemistry/*methods/standards [MESH]
  • |Male [MESH]
  • |Middle Aged [MESH]
  • |Occult Blood [MESH]
  • |RNA, Ribosomal, 16S/genetics [MESH]
  • |ROC Curve [MESH]
  • |Reproducibility of Results [MESH]
  • |Sensitivity and Specificity [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box